| Two phase 3 trials of dupilumab versus placebo in atopic dermatitis EL Simpson, T Bieber, E Guttman-Yassky, LA Beck, A Blauvelt, MJ Cork, ... New England Journal of Medicine 375 (24), 2335-2348, 2016 | 1752 | 2016 |
| Clinical features and management of human monkeypox: a retrospective observational study in the UK H Adler, S Gould, P Hine, LB Snell, W Wong, CF Houlihan, JC Osborne, ... The Lancet Infectious Diseases 22 (8), 1153-1162, 2022 | 1019 | 2022 |
| A living WHO guideline on drugs for covid-19 A Agarwal, BJ Hunt, M Stegemann, B Rochwerg, F Lamontagne, ... bmj 370, 2020 | 953 | 2020 |
| SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ... Cell 185 (3), 467-484. e15, 2022 | 911 | 2022 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 724 | 2021 |
| Pathogenesis of flavivirus infections: using and abusing the host cell MD Fernandez-Garcia, M Mazzon, M Jacobs, A Amara Cell host & microbe 5 (4), 318-328, 2009 | 428 | 2009 |
| Temporal analysis of early immune responses in patients with acute hepatitis B virus infection C Dunn, D Peppa, P Khanna, G Nebbia, M Jones, N Brendish, RM Lascar, ... Gastroenterology 137 (4), 1289-1300, 2009 | 424 | 2009 |
| Two cases of monkeypox imported to the United Kingdom, September 2018 A Vaughan, E Aarons, J Astbury, S Balasegaram, M Beadsworth, ... Eurosurveillance 23 (38), 1800509, 2018 | 395 | 2018 |
| Clinical management of Ebola virus disease in the United States and Europe TM Uyeki, AK Mehta, RT Davey Jr, AM Liddell, T Wolf, P Vetter, ... New England Journal of Medicine 374 (7), 636-646, 2016 | 390 | 2016 |
| Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults B Killingley, AJ Mann, M Kalinova, A Boyers, N Goonawardane, J Zhou, ... Nature Medicine 28 (5), 1031-1041, 2022 | 372 | 2022 |
| Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression M Jones, A Davidson, L Hibbert, P Gruenwald, J Schlaak, S Ball, ... Journal of virology 79 (9), 5414-5420, 2005 | 369 | 2005 |
| Late Ebola virus relapse causing meningoencephalitis: a case report M Jacobs, A Rodger, DJ Bell, S Bhagani, I Cropley, A Filipe, RJ Gifford, ... The Lancet 388 (10043), 498-503, 2016 | 365 | 2016 |
| Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance T Kotecha, DS Knight, Y Razvi, K Kumar, K Vimalesvaran, G Thornton, ... European heart journal 42 (19), 1866-1878, 2021 | 362 | 2021 |
| Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre … CD Russell, CJ Fairfield, TM Drake, L Turtle, RA Seaton, DG Wootton, ... The Lancet Microbe 2 (8), e354-e365, 2021 | 286 | 2021 |
| Dengue virus NS5 inhibits interferon-α signaling by blocking signal transducer and activator of transcription 2 phosphorylation M Mazzon, M Jones, A Davidson, B Chain, M Jacobs The Journal of infectious diseases 200 (8), 1261-1270, 2009 | 272 | 2009 |
| Dengue virus nonstructural protein 1 is expressed in a glycosyl‐phosphatidylinositol‐linked form that is capable of signal transduction MG Jacobs, PJ Robinson, C Bletchly, JM Mackenzie, PR Young The FASEB Journal 14 (11), 1603-1610, 2000 | 221 | 2000 |
| Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study RK Gupta, EM Harrison, A Ho, AB Docherty, SR Knight, M van Smeden, ... The Lancet Respiratory Medicine 9 (4), 349-359, 2021 | 208 | 2021 |
| Ebola virus shedding and transmission: review of current evidence P Vetter, WA Fischer, M Schibler, M Jacobs, DG Bausch, L Kaiser The Journal of infectious diseases 214 (suppl_3), S177-S184, 2016 | 179 | 2016 |
| Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the … CI Bloom, TM Drake, AB Docherty, BJ Lipworth, SL Johnston, ... The Lancet Respiratory Medicine 9 (7), 699-711, 2021 | 164 | 2021 |
| COVID-19: myocardial injury in survivors DS Knight, T Kotecha, Y Razvi, L Chacko, JT Brown, PS Jeetley, ... Circulation 142 (11), 1120-1122, 2020 | 161 | 2020 |
